4.4 Article

Pilot Study of Modified LMB-Based Therapy for Children With Ataxia-Telangiectasia and Advanced Stage High Grade Mature B-Cell Malignancies

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

DNA damage responses: Mechanisms and roles in human disease

Michael B. Kastan

MOLECULAR CANCER RESEARCH (2008)

Article Oncology

Atm deficiency affects both apoptosis and proliferation to augment myc-induced lymphomagenesis

Kirsteen H. Maclean et al.

MOLECULAR CANCER RESEARCH (2007)

Article Pediatrics

Interstitial lung disease in patients with ataxia-telangiectasia

SA Schroeder et al.

PEDIATRIC PULMONOLOGY (2005)

Article Pediatrics

Immunodeficiency and infections in ataxia-telangiectasia

A Nowak-Wegrzyn et al.

JOURNAL OF PEDIATRICS (2004)

Review Biochemistry & Molecular Biology

ATM and ataxia telangiectasia - Second in Molecular Medicine Review Series

PJ McKinnon

EMBO REPORTS (2004)

Article Medicine, General & Internal

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

B Coiffier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Letter Oncology

Severe lung fibrosis after chemotherapy in a child with ataxia-telangiectasia

RL Chen et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)

Article Oncology

Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries

JH Olsen et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)